Compounds for use in the treatment or prophylaxis of pain, inflammation and/or autoimmunity
US11891350B2 · kind B2 · utility
0Cited by
8References
22Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 22, 2020 |
| Grant date | Feb 6, 2024 |
| Priority date | — |
| Expiry date | May 26, 2041 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C2601/16
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to a polymorphic form of (S,S)-2-N(3-O-(propan-2-ol)-1-propyl-4-hydroxybenzene)-3-phenylpropylamide or synonymously named N-[2-(4-Hydroxy-phenyl)-(2-hydroxy-propoxymethyl)-ethyl]-3-phenyl-propionamide and to the treatment or prophylaxis of pain, inflammation and/or autoimmunity and provides a method of treating or preventing pain, inflammation and/or autoimmunity as well as the use of this polymorphic form in the manufacture of medicaments for the treatment or prophylaxis of pain (preferably nociceptive or neuropathic), inflammation and/or autoimmunity in humans and/or non-human animals.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.